The Office of the Commissioner of Baseball announced today that New York Yankees minor leaguer Holman Miranda has been suspended for testing positive for a performance enhancing drug. Miranda, 17, is a switch hitting shortstop out of Nicaragua who made his professional debut this season with the Dominican Summer League Yankees after signing this past March.
Holman will serve a 72-game suspension without pay for testing positive for Nandrolone. The suspension will begin at the beginning of next season. Nandrolone is commonly used to treat osteoporosis in postmenopausal women as well as anemia. Side effects include muscle growth, appetite stimulation, increased red blood cell production and bone density.